Happy International Yoga Day! Whether you're at your work desk or at home, take a break, breathe deeply, and feel the difference. #InternationalYogaDay

Sun Pharma has entered into a non-exclusive patent licensing agreement with Japanese pharmaceutical company, Takeda to introduce a novel Gastrointestinal Drug, Voltapraz (Vonoprazan) in India. Read more here: bit.ly/3xoMY99

The results from a Phase I study evaluating the safety, tolerability, pharmacokinetics & pharmacodynamics of our GL0034 (Utreglutide) in obese adults, were presented at the 84th Scientific Sessions of the American Diabetes Association (ADA). bit.ly/45FqtcO

We are pleased to announce the successful completion of the merger of Taro with Sun Pharma. Read more here: bit.ly/pressreleaseta…

Proud moment for Sun! We've got not one but two feathers in our cap with Great Place To Work® recognizing us as one of India's 50 Best Companies to Work For & Best Employers Among Nation-Builders 2024. #bestemployersamoungnationbuilders #Indiasbestcompaniestoworkfor #GPTWCertified

Engaging panel at the 9th #GPQS2024 on 'Enhancing Current Cybersecurity: Securing the Digital Future' featuring Phani Mitra B (Dr. Reddy’s Laboratories Ltd), Sreeji Gopinathan (Lupin), Dheeraj Sinha (Sun Pharma), & Sanjay Moralwar (Zydus Lifesciences Ltd.).

This #NationalDoctorsDay, sushmita sen joins Sun Pharma in dedicating her #SecondBirthDate to the Doctors who gave her a second chance at life. If you have a similar story, visit secondbirthdate.com to express gratitude to your doctor.

Watch Manisha Koirala’ story behind her second chance at life & why she is dedicating her #SecondBirthDate to her doctors on this #NationalDoctorsDay!

Sreenivas Rao, our Head of Global Supply Chain, shares how Sun's entrepreneurial spirit and strong customer focus have fuelled his dedication to the organization. Discover what drives his passion and commitment by watching his story here. #WeAreSun

The U.S. FDA has approved our new treatment for adults with severe #AlopeciaAreata. Learn more here: l1nq.com/cW7ic

We have announced our Q1 results for FY25. Read more: bit.ly/3AhwikL #ReachingPeopleTouchingLives #Q1Results #FY25 #SunPharma

Our Chairman and Managing Director, Dilip Shanghvi, provides an overview of our Q1 results for FY25. Read more: bit.ly/3AhwikL #Q1Results #FY25 #SunPharma

At Sun, we are dedicated to inspire, support, and empower underprivileged communities by addressing their needs through our social initiatives. See our CSR report for 2023-24: bit.ly/CSRReport23-24 #SunPharma #ReachingPeopleTouchingLives

We marked a significant milestone, honouring doctors' contributions. Over 48,000 Indians dedicated their 'Second Birth Certificates' to the doctors who gave them a second chance at life. Watch sushmita sen dedicate her #secondbirthdate to her doctor: bit.ly/4fsmx3q

Our CMD, Dilip Shanghvi has been honoured as a “Distinguished Fellow of IOD” for 2024 by the Institute Of Directors (IOD), India. Recognising his visionary leadership, IOD has acknowledged his efforts towards driving growth & innovation in the pharma industry, contributing to health & wellness in India.

Sun Pharma wishes you a joyous 78th Independence Day!

Ever wondered what keeps our colleagues going? Watch them share their Sun journey in a nutshell and get inspired! #WeAreSun

We are pleased to share that we have launched the Tedizolid Phosphate tablets 200 mg in India under the brand name “STARIZO”. Read more here: bit.ly/3YQoJfk

Every year, we honour our colleagues who have completed 25 years of service with Sun. This year, 118 awardees gathered in Mumbai to celebrate their remarkable 25-year long journey at ‘Sunmaan 2024’. Stay tuned for stories that highlight their inspiring journeys! #WeAreSun

Our commitment to a culture of trust, forward-thinking leadership, & millennials' holistic well-being has earned us a spot among India’s 50 Best Workplaces™ for Millennials 2024 by Great Place To Work®! We’re the only large-sized ‘Biotech and Pharma’ organisation to get this recognition.